Beta Bionics, Inc. Lease, Cost
Beta Bionics, Inc. (BBNX) reported Lease, Cost of $593.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-07-29
- Beta Bionics, Inc. lease, cost for the quarter ending 2026-06-30 was $593.00K, a 28.35% increase year-over-year.
- Beta Bionics, Inc. lease, cost for the quarter ending 2026-03-31 was $577.00K, a 24.62% increase year-over-year.
- Beta Bionics, Inc. lease, cost for the quarter ending 2025-12-31 was $624.00K, a 24.55% increase year-over-year.
- Beta Bionics, Inc. lease, cost for the quarter ending 2025-09-30 was $491.00K, a 30.93% increase year-over-year.
- Beta Bionics, Inc. lease, cost for fiscal 2025 was $2.04M, a 27.42% increase from fiscal 2024.
- Beta Bionics, Inc. lease, cost for fiscal 2024 was $1.60M, a 38.14% increase from fiscal 2023.
- Beta Bionics, Inc. lease, cost for fiscal 2023 was $1.16M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $593.00K 10-Q · filed 2026-07-29 | $1.17M 10-Q · filed 2026-07-29 | $1.79M derived: sum of 3 quarters · filed 2026-07-29 | $2.29M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $577.00K 10-Q · filed 2026-04-21 | $1.20M derived: sum of 2 quarters · filed 2026-04-21 | $1.69M derived: sum of 3 quarters · filed 2026-04-21 | $2.15M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $624.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.11M derived: sum of 2 quarters · filed 2026-02-24 | $1.58M derived: sum of 3 quarters · filed 2026-07-29 | $2.04M 10-K · filed 2026-02-24 |
| 2025-09-30 | $491.00K 10-Q · filed 2025-10-28 | $953.00K derived: sum of 2 quarters · filed 2026-07-29 | $1.42M 10-Q · filed 2025-10-28 | $1.92M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $462.00K 10-Q · filed 2026-07-29 | $925.00K 10-Q · filed 2026-07-29 | $1.43M derived: sum of 3 quarters · filed 2026-07-29 | $1.80M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $463.00K 10-Q · filed 2026-04-21 | $964.00K derived: sum of 2 quarters · filed 2026-04-21 | $1.34M derived: sum of 3 quarters · filed 2026-04-21 | $1.69M derived: sum of 4 quarters · filed 2026-04-21 |
| 2024-12-31 | $501.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $876.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.23M derived: sum of 3 quarters · filed 2026-02-24 | $1.60M 10-K · filed 2026-02-24 |
| 2024-09-30 | $375.00K 10-Q · filed 2025-10-28 | $725.00K derived: sum of 2 quarters · filed 2025-10-28 | $1.10M 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $350.00K 10-Q · filed 2025-07-29 | $725.00K 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | $375.00K 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $1.16M 10-K/A · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |